Read More Pharma Industry News Janssen acquires HMR59 from Hemera for geographic atrophy treatment Janssen Pharmaceuticals has secured the rights to an innovative gene therapy, HMR59, for the treatment of geographic atrophy,… bypharmanewsdailyDecember 3, 2020
